American Academy of Addiction Psychiatry (AAAP)

08/06/2025

Get your organization in the spotlight this November! AAAP is accepting exhibitors and sponsors for the 36th Annual Meeting and Scientific Symposium in San Francisco 📢

This is your chance to showcase your organization, engage with leading Addiction Psychiatry professionals, and amplify your impact in the field. Whether you’re looking to exhibit your latest innovations or sponsor key aspects of the conference, this is a promotional opportunity to connect with industry leaders and decision-makers.

Why Participate?
✅ Connect with 500-700+ psychiatrists, fellows, and trainees in Addiction Psychiatry
✅ Gain high-impact brand visibility among top Addiction Psychiatry professionals
✅ Network with key stakeholders in addiction treatment, research, and policy
✅ Showcase your products and services to an engaged, mission-driven audience
✅ Strengthen your commitment to advancing Addiction Psychiatry and patient care

Don’t miss out! Elevate your brand and be part of one of the most influential Addiction Psychiatry events of 2025.

08/05/2025

Thinking about enrolling in the 2025 Addictions and Their Treatment (AATT) Virtual Course? 🤔 Hear from Derek Blevins, MD, one of the Course Directors, on what’s in store—and what you’ll miss if you don’t join!

Taking place on September 12-13, this two-day course features:

✅ Top-notch expert presentations and dynamic, interactive Q&A discussions
✅ The latest breakthroughs and trends in addiction, packed into 12 captivating topics
✅ Access to 15 additional on-demand sessions to enhance learning
✅ Access to a 25-question self-assessment exam to reinforce understanding
✅ Content that serves as a complement to last year’s offering, designed to support individuals preparing for the ABPN certification and recertification examinations
✅ The opportunity to earn more than 28 AMA PRA Category 1 Credits™

𝐒𝐞𝐞 𝐰𝐡𝐚𝐭 𝐩𝐚𝐬𝐭 𝐚𝐭𝐭𝐞𝐧𝐝𝐞𝐞𝐬 𝐡𝐚𝐯𝐞 𝐭𝐨 𝐬𝐚𝐲:
💡 9/10 of last year’s attendees said they would recommend this course to a colleague
💡 Past attendees said they found the content to be “excellent, thorough, and easy to understand with stimulating discussions”

Don’t miss this chance to expand your knowledge, connect with leading experts, and strengthen your expertise in addiction!

08/04/2025

AAAP is excited to announce a new recognition it has received from the Accreditation Council for Continuing Medical Education - ACCME. 𝑨𝑨𝑨𝑷 𝒊𝒔 𝒏𝒐𝒘 𝒂𝒏 𝑨𝑪𝑪𝑴𝑬 𝑰𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏 𝑷𝒂𝒓𝒕𝒏𝒆𝒓! ⭐️

ACCME Innovation Partners play a key role in advancing a national system for seamless learner data reporting, working alongside ACCME, state licensing boards, and specialty certifying boards.

AAAP recently received Joint Accreditation with Commendation, the highest level of accreditation offered by the collaboration of the ACCME, the Accreditation Council for Pharmacy Education, and the American Nurses Credentialing Center’s Accreditation Program (American Nurses Enterprise). As an Innovation Partner, AAAP received an additional year of accreditation.

ACCME created the Innovation Partner Program to help accredited providers reduce administrative burdens so their staff and volunteers have more time to support meaningful, lifelong learning. AAAP’s participation in this program helps strengthen the system for everyone!

Innovation Partners are committed to advancing physician learner data reporting by working with ACCME to:

✅ Implement updated integrations
✅ Ensure activities are entered into PARS before their start date
✅ Submit individual physician completions for all applicable activities
✅ Update learner permission policies to support learner data conveyance
✅ Promote the value of claiming a profile on CME Passport, where physicians can easily track and manage their CME credits

As an accredited continuing education provider, AAAP plays a key role in improving the knowledge and performance of physician learners and the entire healthcare team.

08/03/2025

08/01/2025

Join presenter David A. Jobes, PhD, ABPP for this month’s Addiction Psychiatry Advanced Psychotherapy session, “The Collaborative Assessment and Management of Suicidality (CAMS) Approach to Suicidal Risk,” on Wednesday, August 13 from 5:30-7:00 pm EST.

The Collaborative Assessment and Management of Suicidality (CAMS) is one of a handful of suicide-focused clinical treatments with extensive clinical trial support. CAMS is a therapeutic framework that focuses on patient-identified “drivers” of what makes them suicidal. CAMS is patient-centered and focuses on empathy, collaboration, and honesty. As an outpatient intervention, CAMS is designed to form a strong clinical alliance and to increase motivation in the patient with helpful clinical documentation that reduces the risk of malpractice liability.



Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

07/31/2025

A new round of Pcss-Moud Exchange starts on Wednesday, August 6th! 🩺

The PCSS-MOUD Exchange is a 𝗳𝗿𝗲𝗲 four-session course focused on the implementation of prescribing medications for treating opioid use disorder (MOUD) in a variety of healthcare settings. PCSSMOUD-X is intended for an interprofessional audience. Prescribers with frontline experience prescribing MOUD and developing clinic workflows will be available during all four sessions to answer participants’ questions and discuss real-world cases.

🗓️ Session 1 — Explore: Wednesday, August 6 at 3:00 pm EST
🎓 1 CE/CME credit available
𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝗮𝘁𝗼𝗿: Sherry Larkins, PhD
𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗲𝗿𝘀: Nancy Regan-Brooks MSN, FNP, CNM, CARN-AP; Debra Newman, PA-C, MPAS, MPH; and Gavin Bart, MD, PhD, FACP, DFASAM

🗓️ Session 2 — Prepare: Wednesday, August 13 at 3:00 pm EST
🎓 1 CE/CME credit available
𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝗮𝘁𝗼𝗿: Sherry Larkins, PhD
𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗲𝗿𝘀: Kristin Wason, NP; Gavin Bart, MD, PhD, FACP, DFASAM; and Kevin Sevarino, MD, PhD

🗓️ Session 3 — Implement/Sustain: Wednesday, August 20 at 3:00 pm EST
🎓 1 CE/CME credit available
𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝗮𝘁𝗼𝗿: Sherry Larkins, PhD
𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗲𝗿𝘀: Grace Katie Bell, MSN, RN-BC, CARN, PHN; Annie Potter, MSN, MPH, NP, CARN-AP; and Candy Stockton, MD

🗓️ Session 4 — Implement/Sustain: Wednesday, August 27 at 3:00 pm EST
🎓 1 CE/CME credit available
𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝗮𝘁𝗼𝗿: Sherry Larkins, PhD
𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗲𝗿𝘀: Brian Fuehrlein, MD, PhD; Crystal Walker, DMSc, MPAS, PA-C; and Hector Colon-Rivera, MD, MBA, MRO, FAPA

𝙃𝙖𝙫𝙚 𝙮𝙤𝙪 𝙖𝙡𝙧𝙚𝙖𝙙𝙮 𝙩𝙖𝙠𝙚𝙣 𝙋𝘾𝙎𝙎-𝙈𝙊𝙐𝘿 𝙀𝙭𝙘𝙝𝙖𝙣𝙜𝙚? 𝙏𝙚𝙡𝙡 𝙮𝙤𝙪𝙧 𝙘𝙤𝙡𝙡𝙚𝙖𝙜𝙪𝙚𝙨! 🗣️



Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

07/30/2025

Wondering what’s in store for the 2025 Advanced Addiction Psychopharmacology (AAP) Virtual Course? Get the inside scoop from Course Director John Mariani, MD in the video below! 👇

Taking place on September 20-21, this two-day course features:

✅ Live webinar sessions with expert presenters
✅ Interactive Q&A discussions to explore key concepts in depth
✅ Timely topics that match the evolving landscape of addiction care, including an exciting 𝑵𝑬𝑾 session on brain stimulation techniques
✅ Pre-course access to on-demand lectures ahead of the live sessions, allowing for flexible preparation and a more enriched learning experience
✅ An in-depth educational experience for clinicians looking to build on their existing knowledge base
✅ 14 AMA PRA Category 1 Credits™

𝐖𝐡𝐚𝐭’𝐬 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 𝐭𝐡𝐢𝐬 𝐲𝐞𝐚𝐫:
This year’s course offers a broad approach to addiction pharmacotherapy without emphasizing co-occurring disorders. The content, format, and faculty provide a fresh learning experience even for returning participants while complementing last year’s course.

If you treat patients with substance use disorders (and you do), AAP is a 𝗺𝘂𝘀𝘁.

07/29/2025

From groundbreaking research to innovative treatment approaches, the AAAP 36th Annual Meeting and Scientific Symposium will be jam-packed with the latest clinical insights in the field of Addiction Psychiatry.

📣 PLUS: This year’s meeting introduces an 𝑨𝑳𝑳-𝑵𝑬𝑾 debate format!

𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝗮
🔷 Treating Beyond the City Limits: Building Capacity in All Communities
Chairperson: James Berry, DO
Presenters: Daniel Elswick, MD; Wanhong Zheng, MD; Kari Law, MD; and James Berry, DO

🔷 From Trends to Treatment: Advancing Care for Perinatal Substance Use Disorders
Chairperson: Marie Hayes, PhD
Presenters: Constance Guille, MD; Sara Witcraft, PhD; Courtney King, PhD; Marie Hayes, PhD; and Rubin Aujla, MD

🔷 Breaking Ground: A Legacy of Gender-Specific Addiction Research in the NIDA Clinical Trials Network
Chairperson: Shelly Greenfield, MD, MPH
Presenters: Aimee Campbell, PhD; Denise Hien, PhD, ABPP; Dawn Sugarman, PhD; Michelle Lofwall, MD; Christi Patten, PhD, MA, LP; Margaret Paschen-Wolff; and Shelly Greenfield, MD, MPH

🔷 S*x, Gambling and Social Media: Update on Treatment and Research of Behavioral Addictions
Chairperson: Kenneth Rosenberg, MD
Co-Chairperson: Lisa Goldfarb, MD
Presenters: Tim Fong, MD; Jon Grant, MD;
and Kenneth Rosenberg, MD

𝗠𝗶𝗻𝗶-𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺
🔷 Changing the Landscape: SAMHSA’s 2024 Rule and the Future of Opioid Treatment
Chairperson: Hillary Tamar, MD
Presenters: Andrew Schreier; Hillary Tamar, MD; and Frazer Grant, MD

𝗗𝗲𝗯𝗮𝘁𝗲 - 𝗡𝗘𝗪!
🔷 The High-Stakes Debate: Promises and Perils of Psychedelics in Addiction Treatment
Chairperson: Joao De Aquino, MD
Presenters: Peter Hendricks, PhD; Stephen Ross, MD; and Joao De Aquino, MD
Discussants: Albert Garcia-Romeu, PhD; Deepak Cyril D’Souza, MD; Bertha Madras, PhD; and Christopher Pittenger, MD, PhD

The knowledge gained during the meeting will help you be at the forefront of the diagnosis and treatment of substance use disorders and co-occurring psychiatric disorders. There is no better opportunity to network, learn, and grow as a professional in the field of Addiction Psychiatry.

07/28/2025

📢 Just released: 2024 National Survey on Drug Use and Health ( ) findings on U.S. mental health, substance use, treatment and recovery. Now with 4 years of comparable data! samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases/2024

07/25/2025

𝗡𝗲𝘄 𝗽𝗼𝗱𝗰𝗮𝘀𝘁 𝗮𝗹𝗲𝗿𝘁! 🎙️ Tune in to 𝘐𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘪𝘯 𝘈𝘤𝘵𝘪𝘰𝘯: 𝘉𝘶𝘪𝘭𝘥𝘪𝘯𝘨 𝘚𝘵𝘳𝘰𝘯𝘨𝘦𝘳 𝘊𝘰𝘮𝘮𝘶𝘯𝘪𝘵𝘪𝘦𝘴, sponsored by ORN partner organization AMERSA (Assoc. for Multidisciplinary Edu. & Research in Substance use & Addiction).

This new ORN podcast is highlighting cutting-edge programs and collaborative efforts supporting individuals and communities affected by substance use disorders. Featuring multidisciplinary teams, the podcast explores innovative solutions with the potential to transform care and foster stronger, healthier communities.

All episodes will feature a follow-up live discussion a week after release, highlighting an innovative program or collaboration featured in the show. Each discussion will focus on developing practical strategies for adapting and implementing the discussed initiatives in communities to expand access to substance use care and improve health outcomes.

07/24/2025

: Registration is now 𝐎𝐏𝐄𝐍 for the 2025 Advanced Addiction Psychopharmacology (AAP) Virtual Course taking place September 20-21! 📣

This two-day course features live webinar discussions and interactive Q&A sessions, designed for learners with a foundational understanding of Addiction Psychiatry. Participants will gain a deeper, more comprehensive education in the pharmacotherapy of substance use disorders.

This year, we’re introducing timely topics that match the evolving landscape of addiction care, such as:

🔻Kevin Sevarino, MD, PhD: Opioid Use Disorder Pharmacotherapy: Oral OUD Pharmacotherapy and Pain Management
🔻John Mariani, MD: Opioid Use Disorder Pharmacotherapy: Injectable OUD Pharmacotherapy
🔻Richard Rosenthal, MD: Alcohol Use Disorder Pharmacotherapy: From Detox to Relapse Prevention; Medication Treatments for AUD
🔻Jill Williams, MD: Ni****ne Use Disorder Pharmacotherapy: An Underused Arsenal: Varenicline, Bupropion, and NRT
🔻Larissa Mooney, MD with John Mariani, MD and Kevin Sevarino, MD, PhD: Stimulant Use Disorder Pharmacotherapy: Clinical Effects and Treatment Issues
🔻Christina Brezing, MD: Sedative-Hypnotic Use Disorder Pharmacotherapy: Inpatient and Outpatient Medication Approaches
🔻Kevin Gray, MD: Cannabis Use Disorder Pharmacotherapy: Promising Approaches on the Horizon
🔻Diana Martinez, MD: Brain Stimulation for Addiction: Present & Future - 𝑵𝑬𝑾!

Before the live sessions, learners will have access to on-demand lectures to review at their convenience. During the live component, participants will engage directly with expert presenters, who will address questions and expand on key topics covered in the lectures.

𝐖𝐡𝐚𝐭’𝐬 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 𝐭𝐡𝐢𝐬 𝐲𝐞𝐚𝐫:
Unlike last year’s 14-hour online course, which focused on pharmacotherapies for substance use disorders with co-occurring psychiatric conditions, this year’s course offers a broader approach to addiction pharmacotherapy without emphasizing co-occurring disorders. The content, format, and faculty provide a fresh learning experience even for returning participants while complementing last year’s course.

Don’t miss this opportunity to deepen your clinical insights, connect with top educators, and strengthen your expertise in treating addictions!

07/22/2025

Case conference submissions for the 36th AAAP Annual Meeting and Scientific Symposium are due by Sunday, August 3! 📢

🗣️ Case Conference
To promote lively and thoughtful discussion regarding the clinical management of patients with substance use disorders. A compelling case that touches on numerous relevant and current issues in such management serves as the foundation for the discussion.
👤 Submitter: Trainees (fellows, residents, and medical students)
💡 Type: Didactic session
🕝 Duration: 90 minutes
#️ Number of presenters: 1 plus discussants
✔️ Total number accepted: 1